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S284 Poster Session I(88,8%). Underlying diseases CML(1 p), CMML(1 p), AML(2 p),
ALL(3 p), SAA(2 p). Disease state at time of transplant: Refractory
disease: 7 p (77,7%). Conditioning Regimen: Reduced intensity: 6
p (66,6%). ATG(5 p)/CAMPATH-1H(1 p):6 p (66,6%). Donors
Matched Unrelated: 4 p, Mismatched Unrelated: 3 p, Mismatched
Related: 2 p. Graft source: peripheral blood stem cells: 9 p (100%).
Acute GVHD II-IV: 5 p(55,5%) requiring high-doses corticoste-
roids. CMV reactivation: 5 p (55,5%). Pandemic Influenza A
(H1N1) Infection: 1 p (11,1%). All patients had serum Galacto-
mannan(GM) assayed twice weekly.
Results:Median time on prophylaxis was 85(range14-241)days. GM
was positive(+) in three patients (33,3%) at onset PAF-Px VOR.
Breakthrough Invasive Fungal Infections: Candidemia caused by
Candida Glabrata (1 p) (Susceptible to fluconazole and VOR) and
probable IA(EORTC/MSG criteria) (1 p GM + at baseline): 2 p
(22,2%).None of these p died of Invasive Fungal Infection. VOR
therapywasnot discontinued in anypatient becauseof adverse effects.
Seven patients died during the follow up. Cause of death: Relapse:3
p,GVHD:2 p,VOD:1 p,Disseminated Adenovirus infection:1 p.
Conclusion: PAF-Px with VOR was an effective and well tolerated
regimen for Invasive Fungal Infections prevention in this high-risk
patient population studied.CRA – DATA MANAGEMENT
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TWO YEAR EVALUATION OF EVENT REPORTING SYSTEM FOR THE CELL
THERAPY PROCESSING FACILITY
Merchant, M.1, Kletzel, M.1,2, Shook, T.1, Villa, M.1, Meagher, R.1,
Gordon, L.1 1NorthwesternMemorial Hospital & Feinberg School ofMed-
icine, Chicago, IL; 2Children’s Memorial Hospital & Robert H Lurie
Comprehensive Cancer Center, Chicago, IL
Background: The Cell Therapy Processing Facility (CTPF) at
Northwestern Memorial Hospital devised and implemented a new
Event Reporting System (ERS) in September 2008, to capture all
events occurring in theCTPF, so as to improve the quality, efficiency
and safety of the laboratory, its patient, product and personnel.
Events were classified according to their severity from Class I to VI.
Event Classification: I HCT/P Deviation; II SOP Deviation; III
Planned Deviation; IV Equipment/Supply related; V Complaint;
VI Other.
Objective:The reason behind implementing a new ERSwas to clas-
sify events in proper perspective so that we could document the ex-
tent of errors in the CTPF and to further offer solutions to prevent
them from recurring.
Method: Events were recorded for the fiscal year from October
through September. Events between October 2007 and September
2008 were re-classified according to the new system (2008). Events
were recorded against the number of transplants performed, for pur-
pose of comparison. The ERS uses single page reporting with check
boxes for ease in use. It is open to all employees and to all participat-
ing program personnel; and is non-biased and non-discriminatory.
All events, however minor, were encouraged to be reported.
Result:
Table 1.






1n5 69 n5 188 n5 163Class I 2 (3%) 7 (4%) 2 (1%)
Class II 11 ( 6%) 50 27%) 37 ( 3%)
Class III 40 ( 8%) 91 48%) 90 ( 5%)
Class IV 14 ( 0%) 30 16%) 21 ( 3%)
Class V 0 3 (2%) 0
Class VI 2 (3%) 7 (4%) 13 (8%)
No of Transplants 344 401 415
Events Over Transplants 20.1% 46.9% 39.3%
Class I & II Events Over Transplants 3.8% 14.2% 9.4%
Class III Events Over Transplants 11.6% 22.7% 21.7%
Class IV to VI Events Over Transplants 4.7% 10% 8.2%Discussion: We observed that prior to the implementation of the
ERS, many events went undocumented, especially those related to
infectious disease markers, product labeling and those related to
cell processing. Events related to HCT/P or SOP deviation (Class
I & II) are very concerning to any laboratory. The ERS detected
that in 2009, these were at 14.2%, up from 3.8% in 2008.We under-
took an overhaul and revision of our SOP with the current accredit-
ing and regulatory guidelines in mind. Policies were discussed before
and during their writing, training and implementation. Policies are
now sufficiently detailed to cover many possible event scenarios.
The SOP is secured from inadvertent altering or tampering, and is
easy to access and readily available to technicians on the workbench.
Training, retraining and competency issues have been sorted out.
This, we believe has helped us lower the occurence of these events
by 5% in 2010.
Conclusion: Implementing a new ERS has made us aware of the
scope of events in the CTPF and helped us in identifying the key rea-
son behind the events; thus leading to a decline in their number over
two years and especially, a decline in the severity of Class I & II
errors.361
EXPERIENCES FROM TRAINING A DATA MANAGER AT A NEW STEM CELL
TRANSPLANT CENTER
Roepstorff, C., Petersen, H., Larsen, H.B. Rigshospitalet, Finsencentret,
Copenhagen, Denmark
Introduction: Previously there was only one allogeneic trans-
plant centre in Denmark, however due to an increased need
for allogeneic transplants a second center was opened in 2009.
The new center is self-governed with an independent centre ad-
ministration and economy. Upon request the ‘‘old’’ center was
asked to assist in development and training of a data manager
and SCT-team. However, the new center could make indepen-
dent decisions regarding choise of regestries and organization
of work procedures.
Purpose: To describe and discuss the challenges involved in devel-
opmet and training of a data manager (and SCT-team) at a new self-
govening allogeneic transplant center.
Results: The training program for data collection included train-
ing of the following persons from the new center on the following
issues:
A ½ day training of a physician and head nurse: Overall introduc-
tion to data structure and data flow to registries such as the EBMT,
CIBMTR and donor centers including the type of information
needed to be present in the patients’ medical records in order to com-
plete these requirements. Estimated time consumption to complete
the data requirements.
A ½ day of training of a transplant coordinatior: Introduc-
tion to the data manager function, and informaton needed in
the patients’ medical records in order to fulfill the data re-
quirements.
A 2 day training of a data manager: Overall introduction to the
data structure and data flow, the EBMT, CIBMTR and donor reg-
istries and collaboration partners. Further, detailed infomration on
how to organize a patient numbering system, the work load and
keeping track of patients. Introduction on how to fill out different
types of patient reports and how to tab patient information in two
different data base systems. Introduction of the GvHD grading sys-
tems, transplant complications (VOD, TAM etc.), causes of death,
definition, and of difficult questions in the forms. Additionally, the
data manager was provided with guidelines, definitions, instructions,
tools and tips to help ease the work.
Conclusion: For new data managers the medical knowledge re-
quired to complete the forms to the different registries can
seem comprehensive. Training a data manager in a new center
faces the challenges of how the new center wishes to organize
their level of data gathering and reporting and challenges the
‘‘old’’ centers way of organizing the workflow. Cooperation be-
tween different transplant centers on data reporting is beneficial
to both centers.
